Importance of Illness Acceptance Among Other Factors Affecting Quality of Life in Acromegaly
- PMID: 32010060
- PMCID: PMC6972500
- DOI: 10.3389/fendo.2019.00899
Importance of Illness Acceptance Among Other Factors Affecting Quality of Life in Acromegaly
Abstract
Introduction: The aim of this study was to analyze psychological factors of patients with acromegaly and assessment of their relationship with the quality of life (QoL) in the context of the control of the disease. Materials and methods: A total sample of 50 patients (62% of females; mean age = 51.66 ± 14.5) with acromegaly underwent a comparative, cross-sectional cohort assessment including the QoL (AcroQoL, WHOQoL-BREF), psychiatric morbidity (GHQ-28), the acceptance of illness (AIS) as well as influence of treatment, comorbidities and symptoms in the relation of disease activity. Acromegaly group was divided in two subgroups: patients with uncontrolled acromegaly (UA, n = 28) and patients with controlled acromegaly (CA, n = 22). Results: The acromegaly groups did not differ in health-related QoL measured with AcroQoL and WHOQoL questionnaires. However, obtained results showed QoL impairments in all subscales and the study participants had decreased scores compared to reference values. The interaction of the relationship between the AIS and disease activity as well as the prevalence of all psychopathological symptoms and disease activity were tested and the statistically significantly differences in the context of QoL in AcroQoL questionnaires and its domains were observed in relation to the course of the disease. No difference in acromegaly symptoms as well as in number of comorbidities were found between CA and UA but these two parameters affected the results QoL scores in AcroQol questionnaires and their domains, regardless the disease activity. Similarly, the prevalence of psychopathological symptoms (GHQ-28) contributed the level of acceptance of the disease, regardless the disease activity. The strongest predictors of QoL were related to the level of illness acceptance (p = 0.01) as well as serum growth hormone concentration. Conclusion: Minding people with UA, the control of biochemical factors seemed to be more important for the QoL perception, while among CA, psychological variables such as AIS are observed to play a fundamental role in QoL. Moreover, inclusion of patient's acceptance of the illness into clinical routine would promote holistic, patient-centered care and empower doctor-patient partnership where patients' expectations and perceptions are constantly tracked. Obtaining biochemical control should not be considered as the only measure of treatment success.
Keywords: acceptance of illness; acromegaly; disease activity; psychopathology; quality of life.
Copyright © 2020 Jawiarczyk-Przybyłowska, Szcześniak, Ciułkowicz, Bolanowski and Rymaszewska.
Similar articles
-
Is there any difference in acromegaly and other chronic disease in quality of life and psychiatric morbidity?Endokrynol Pol. 2017;68(5):524-532. doi: 10.5603/EP.a2017.0044. Epub 2017 Sep 7. Endokrynol Pol. 2017. PMID: 28879648
-
Quality of life (QOL) in patients with acromegaly is severely impaired: use of a novel measure of QOL: acromegaly quality of life questionnaire.J Clin Endocrinol Metab. 2005 Jun;90(6):3337-41. doi: 10.1210/jc.2004-1565. Epub 2005 Mar 8. J Clin Endocrinol Metab. 2005. PMID: 15755865
-
Impaired quality of life in patients with treated acromegaly despite long-term biochemically stable disease: Results from a 5-years prospective study.Clin Endocrinol (Oxf). 2017 Jun;86(6):806-815. doi: 10.1111/cen.13331. Epub 2017 Apr 18. Clin Endocrinol (Oxf). 2017. PMID: 28316090
-
Predictors of Quality of Life in Acromegaly: No Consensus on Biochemical Parameters.Front Endocrinol (Lausanne). 2017 Mar 3;8:40. doi: 10.3389/fendo.2017.00040. eCollection 2017. Front Endocrinol (Lausanne). 2017. PMID: 28316591 Free PMC article. Review.
-
Quality of life in acromegaly.Neuroendocrinology. 2006;83(3-4):224-9. doi: 10.1159/000095532. Epub 2006 Oct 13. Neuroendocrinology. 2006. PMID: 17047387 Review.
Cited by
-
Patient Characteristics, Diagnostic Delays, Treatment Patterns, Treatment Outcomes, Comorbidities, and Treatment Costs of Acromegaly in China: A Nationwide Study.Front Endocrinol (Lausanne). 2020 Dec 1;11:610519. doi: 10.3389/fendo.2020.610519. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 33335513 Free PMC article.
-
Complications and Comorbidities of Acromegaly-Retrospective Study in Polish Center.Front Endocrinol (Lausanne). 2021 Mar 16;12:642131. doi: 10.3389/fendo.2021.642131. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33796075 Free PMC article.
-
Quality of Life and Sleep in Patients with Pituitary Adenoma in Relation to Tumor Type and Compression of the Optic Chiasm.J Clin Med. 2021 Apr 26;10(9):1879. doi: 10.3390/jcm10091879. J Clin Med. 2021. PMID: 33926090 Free PMC article.
-
Updates in rare and not-so-rare complications of acromegaly: focus on respiratory function and quality of life in acromegaly.F1000Res. 2020 Jul 29;9:F1000 Faculty Rev-791. doi: 10.12688/f1000research.22683.1. eCollection 2020. F1000Res. 2020. PMID: 32765836 Free PMC article. Review.
-
Global psychological assessment with the evaluation of life and sleep quality and sexual and cognitive function in a large number of patients with acromegaly: a cross-sectional study.Eur J Endocrinol. 2022 Dec 13;187(6):823-845. doi: 10.1530/EJE-22-0263. Print 2022 Dec 1. Eur J Endocrinol. 2022. PMID: 36165745 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources